Osteoid Osteoma and Osteoblastoma Areosteogenic Commonly Bone Seen Neoplasms

Total Page:16

File Type:pdf, Size:1020Kb

Osteoid Osteoma and Osteoblastoma Areosteogenic Commonly Bone Seen Neoplasms Review Article Osteoid Osteoma and Osteoblastoma 12/02/2019 on u/IbxyW10PyB2YElQSx553TwN8VxsYCiZA5XrK0/cP/SCpUSBb7JMj6d1Ekjs016BH/IiOppl5yk1QrhahWY4dmkQx6hwiC5aPRlV2DVnBAgWs7gdhpPEkx2dlG58Dkr8eqv7+kEVTc= by https://journals.lww.com/jaaos from Downloaded Abstract Downloaded Kivanc I. Atesok, MD, MSc Osteoid osteoma and osteoblastoma are commonly seen benign osteogenic bone neoplasms. Both tumors are typically seen in the from Benjamin A. Alman, MD, https://journals.lww.com/jaaos FRCSC second decade of life, with a notable predilection in males. Emil H. Schemitsch, MD, Histologically, these tumors resemble each other, with FRCSC characteristically increased osteoid tissue formation surrounded by Amos Peyser, MD vascular fibrous stroma and perilesional sclerosis. However, by osteoblastomas are larger than osteoid osteomas, and they exhibit u/IbxyW10PyB2YElQSx553TwN8VxsYCiZA5XrK0/cP/SCpUSBb7JMj6d1Ekjs016BH/IiOppl5yk1QrhahWY4dmkQx6hwiC5aPRlV2DVnBAgWs7gdhpPEkx2dlG58Dkr8eqv7+kEVTc= Henry Mankin, MD greater osteoid production and vascularity. Clinically, osteoid osteoma most commonly occurs in the long bones (eg, femur, tibia). The lesions cause night pain that is relieved with nonsteroidal anti-inflammatory drugs (NSAIDs). Osteoblastoma is most frequently located in the axial skeleton, and the pain is usually not worse at night and is less likely to be relieved with NSAIDs. Osteoblastoma can be locally aggressive; osteoid osteoma lacks growth potential. Osteoid osteoma may be managed nonsurgically with NSAIDs. When surgery is required, minimally invasive methods (eg, CT-guided excision, radiofrequency ablation) are preferred. Osteoblastoma has a higher rate of recurrence than does osteoid osteoma, and patients must be treated surgically with intralesional curettage or en bloc resection. steoid osteoma and osteoblas- mors.1,5 This lesion most commonly Otoma are benign bone-forming occurs in persons aged 5 to 25 years, From the Institute of Medical skeletal neoplasms that are charac- with a male:female ratio of 2:1.6,7 In Science, University of Toronto, terized by the formation of osteoid >50% of cases, the lesion occurs in Toronto, ON, Canada (Dr. Atesok), or mature bone directly by the tumor the Division of Orthopaedic Surgery, the metaphysis and diaphysis of the 1 The Hospital for Sick Children, cells. Together, these tumors repre- long bones, particularly the femur Toronto (Dr. Alman), the Division of sent approximately 15% of all be- and tibia.6,7 Other anatomic sites of Orthopaedics, Department of nign skeletal neoplasms, and they are involvement include the spine, upper Surgery, St. Michael’s Hospital, on University of Toronto, Toronto commonly encountered by orthopae- extremity, pelvis, sacrum, ribs, 12/02/2019 2,3 (Dr. Schemitsch), the Department of dic surgeons in the clinical setting. hands, and feet4 (Table 1). Orthopedics, Shaare Zedek Medical Center, Jerusalem, Israel Gross Structure and (Dr. Peyser), and the Department of Osteoid Osteoma Orthopaedic Surgery, Massachusetts Histology General Hospital, Boston, MA (Dr. Mankin). Osteoid osteoma was first described Observed grossly, the lesion is usu- in 1935 by Jaffe, who also coined the ally <1.5 cm in diameter and con- J Am Acad Orthop Surg 2011;19: term.4 It is the most commonly seen be- 678-689 tains a discrete central area known nign bone-forming lesion, accounting as the nidus that is surrounded by Copyright 2011 by the American for 10% to 12% of all benign bone tu- dense sclerotic bone tissue.8 In gen- Academy of Orthopaedic Surgeons. mors and 3% of all primary bone tu- eral, osteoid osteoma is a solitary le- 678 Journal of the American Academy of Orthopaedic Surgeons Kivanc I. Atesok, MD, MSc, et al Table 1 Features of Osteoid Osteoma and Osteoblastoma Osteoid Osteoma Osteoblastoma Incidence ≈12% of all benign bone tumors ≈3% of all benign bone tumors ≈3% of all primary bone tumors ≈1% of all primary bone tumors Age 5to25yr 10to25yr Sex Male:female ratio of 2:1 Male:female ratio of 2:1 Size <2 cm in diameter (typically <1.5 cm) >2 cm in diameter (average, 3.5 to 4 cm) Location >50% of lesions in the lower extremity long bones >35% of lesions in the vertebral column (posterior ele- (ie, femur, tibia). Other common sites: spine, upper ments). Other common sites: long bones, craniofacial extremity, hands, feet, and pelvis bones, hands, and feet Clinical features Local pain that is most severe at night and can be re- Dull, aching, progressive local pain. Due to higher inci- lieved with nonsteroidal anti-inflammatory drugs. De- dence of spinal involvement, patients may experience pending on location, patients may present with bone neurologic symptoms, scoliosis, or torticollis. Local deformity, gait disturbance, limb-length discrepancy, tenderness and swelling may be seen. or synovitis. Imaging findings Plain radiograph is obtained initially, but supportive Plain radiograph obtained initially. Lesions are larger. imaging is required. Supportive imaging is required. Bone scan: Sensitive and valuable in localizing the Bone scan: Sensitive. Shows high uptake of radionu- lesion. Shows high uptake. clide at the lesion site. CT: Imaging method of choice. Shows the low- CT: Imaging method of choice. Larger lesion, central attenuated nidus with surrounding sclerosis. mineralization, expansile bone growth, less reactive MRI is controversial: Nonspecific findings with frequent sclerosis, thin marginal bone shell. misinterpretation. MRI is controversial: Nonspecific findings with overesti- mation of tumor extent and nature. Histology and Central nidus composed of tiny osteoid islands lined Centrally, lesions demonstrate a less organized osteoid nature by osteoblasts. The area peripheral to the nidus ap- pattern than osteoid osteoma, with greater vascularity. pears clearer because of osteoclastic resorption. Bony trabeculae lined by osteoblasts. Presence of Dense sclerotic bone surrounds the nidus. Benign. epithelioid osteoblasts indicates aggressiveness. Less No growth potential. sclerotic bone with a thin shell of newly formed peri- osteal bone at the margin. Benign. Growth is local- ized, with aggressive potential. sion; in rare cases, however, more gives rise to a clearer area at the pe- Biology and than one nidus may be circumscribed riphery of the circular nidus. The ni- Pathophysiology 9,10 by a single block of sclerotic bone. dus is surrounded by a region of ac- Schulman and Dorfman11 demon- Microscopically, the nidus is com- tive bone formation that appears as strated abundant nerve fibers within posed of thin seams of osteoid or sclerotic dense bone with various the nidus matrix adjacent to areas woven bone lined with osteoblasts, patterns of maturation.1,4 rich in arterioles. High levels of pros- which represents a process of bone Osteoid osteoma does not grow or taglandin synthesis in the nidus of remodelling with osteoblastic activ- behave in a locally aggressive man- osteoid osteoma have been reported ity (Figure 1). Osteoclastic bone re- ner, and it has no potential for malig- in several other studies.12,13 This find- sorption occurs simultaneously and nant transformation.4,6 ing was supported by studies demon- Dr. Atesok or an immediate family member serves as a board member, owner, officer, or committee member of the International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine and the Orthopaedic Research Society. Dr. Alman or an immediate family member serves as a board member, owner, officer, or committee member of the Pediatric Orthopaedic Society of North America. Dr. Schemitsch or an immediate family member has received royalties from Stryker; serves as a paid consultant to Amgen, Stryker, Synthes, Smith & Nephew, Baxter, Wright Medical Technology, and Kuros; has received research or institutional support from Smith & Nephew; has received nonincome support (such as equipment or services), commercially derived honoraria, or other non-research–related funding (such as paid travel) from the Canadian Institutes of Health Research, BrainLAB, OMEGA, Smith & Nephew, Zimmer, and Stryker; and serves as a board member, owner, officer, or committee member of the Orthopaedic Trauma Association, Canadian Orthopaedic Association, and Osteosynthesis and Trauma Care Foundation. Neither of the following authors nor any immediate family member has received anything of value from or owns stock in a commercial company or institution related directly or indirectly to the subject of this article: Dr. Peyser and Dr. Mankin. November 2011, Vol 19, No 11 679 Osteoid Osteoma and Osteoblastoma Figure 1 Figure 2 A, AP radiograph demonstrating an osteoid osteoma nidus in the base of the Histologic appearance of an area fifth metatarsal (arrows). B, Bone scintigraphy image demonstrating within a nidus in a patient with increased radionuclide uptake by the lesion in the affected foot, at the left, osteoid osteoma. The bony and no abnormal findings in the contralateral foot at the right. (Panel A trabeculae are rimmed by adapted with permission from Peyser A, Applbaum Y: Radiofrequency osteoblasts (arrow). Capillaries can ablation of bone tumors. Current Orthopaedic Practice 2009;20[6]:616-621.) be detected between the bony trabeculae (arrowhead) (hematoxylin-eosin, high-power view). (Adapted with permission from Zbojniewicz AM, Hartel J, pending on the proximity to a joint, the tumor often leads the clinician to Nguyen T, Wilks K, Mace A, Hogg clinician may note effusion, synovitis, strongly consider a diagnosis of os- JP: Neoplastic disease of the degenerative changes,
Recommended publications
  • Bone and Soft Tissue Tumors Have Been Treated Separately
    EPIDEMIOLOGY z Sarcomas are rare tumors compared to other BONE AND SOFT malignancies: 8,700 new sarcomas in 2001, with TISSUE TUMORS 4,400 deaths. z The incidence of sarcomas is around 3-4/100,000. z Slight male predominance (with some subtypes more common in women). z Majority of soft tissue tumors affect older adults, but important sub-groups occur predominantly or exclusively in children. z Incidence of benign soft tissue tumors not known, but Fabrizio Remotti MD probably outnumber malignant tumors 100:1. BONE AND SOFT TISSUE SOFT TISSUE TUMORS TUMORS z Traditionally bone and soft tissue tumors have been treated separately. z This separation will be maintained in the following presentation. z Soft tissue sarcomas will be treated first and the sarcomas of bone will follow. Nowhere in the picture….. DEFINITION Histological z Soft tissue pathology deals with tumors of the classification connective tissues. of soft tissue z The concept of soft tissue is understood broadly to tumors include non-osseous tumors of extremities, trunk wall, retroperitoneum and mediastinum, and head & neck. z Excluded (with a few exceptions) are organ specific tumors. 1 Histological ETIOLOGY classification of soft tissue tumors tumors z Oncogenic viruses introduce new genomic material in the cell, which encode for oncogenic proteins that disrupt the regulation of cellular proliferation. z Two DNA viruses have been linked to soft tissue sarcomas: – Human herpes virus 8 (HHV8) linked to Kaposi’s sarcoma – Epstein-Barr virus (EBV) linked to subtypes of leiomyosarcoma z In both instances the connection between viral infection and sarcoma is more common in immunosuppressed hosts.
    [Show full text]
  • Osteoid Osteoma: Contemporary Management
    eCommons@AKU Section of Orthopaedic Surgery Department of Surgery 2018 Osteoid osteoma: Contemporary management Shahryar Noordin Aga Khan University, [email protected] Salim Allana Emory University Kiran Hilal Aga Khan University, [email protected] Riaz Hussain Lukhadwala Aga Khan University, [email protected] Anum Sadruddin Pidani Aga Khan University, [email protected] See next page for additional authors Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_orthop Part of the Orthopedics Commons, Radiology Commons, and the Surgery Commons Recommended Citation Noordin, S., Allana, S., Hilal, K., Lukhadwala, R. H., Pidani, A. S., Ud Din, N. (2018). Osteoid osteoma: Contemporary management. Orthopedic Reviews, 10(3), 108-119. Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_orthop/92 Authors Shahryar Noordin, Salim Allana, Kiran Hilal, Riaz Hussain Lukhadwala, Anum Sadruddin Pidani, and Nasir Ud Din This article is available at eCommons@AKU: https://ecommons.aku.edu/pakistan_fhs_mc_surg_orthop/92 Orthopedic Reviews 2018; volume 10:7496 Osteoid osteoma: Contemporary management Epidemiology Correspondence: Shahryar Noordin, Orthopaedic Surgery, Aga Khan University, Osteoid osteoma accounts for around Karachi, Pakistan. Shahryar Noordin,1 Salim Allana,2 5% of all bone tumors and 11% of benign Tel.: 021.3486.4384. 4 Kiran Hilal,3 Naila Nadeem,3 bone tumors. Osteoid osteoma is the third E-mail: [email protected] Riaz Lakdawala,1 Anum Sadruddin,4 most common biopsy analyzed benign bone 5 tumor after osteochondroma and nonossify- Key words: Osteoid osteoma; tumor; benign; Nasir Uddin imaging; pathogenesis; management. 1 ing fibroma. Two to 3% of excised primary Orthopaedic Surgery, Aga Khan bone tumors are osteoid osteomas.5 Males University, Karachi, Pakistan; Contributions: SN, SA, study design, data col- are more commonly affected with an lection, manuscript writing; KH, NU, data col- 2 5 Department of Epidemiology, Rollins approximate male/female ratio of 2 to 1.
    [Show full text]
  • View Presentation Notes
    When is a musculoskeletal condition a tumor? Recognizing common bone and soft tissue tumors Christian M. Ogilvie, MD Assistant Professor of Orthopaedic Surgery University of Pennsylvania University of Pennsylvania Department of Orthopaedic Surgery Purpose • Recognize that tumors can present in the extremities of patients treated by athletic trainers • Know that tumors may present as a lump, pain or both • Become familiar with some bone and soft tissue tumors University of Pennsylvania Department of Orthopaedic Surgery Summary • Introduction – Pain – Lump • Bone tumors – Malignant – Benign • Soft tissue tumors – Malignant – Benign University of Pennsylvania Department of Orthopaedic Surgery Summary • Presentation • Imaging • History • Similar conditions –Injury University of Pennsylvania Department of Orthopaedic Surgery Introduction •Connective tissue tumors -Bone -Cartilage -Muscle -Fat -Synovium (lining of joints, tendons & bursae) -Nerve -Vessels •Malignant (cancerous): sarcoma •Benign University of Pennsylvania Department of Orthopaedic Surgery Introduction: Pain • Malignant bone tumors: usually • Benign bone tumors: some types • Malignant soft tissue tumors: not until large • Benign soft tissue tumors: some types University of Pennsylvania Department of Orthopaedic Surgery Introduction: Pain • Bone tumors – Not necessarily activity related – May be worse at night – Absence of trauma, mild trauma or remote trauma • Watch for referred patterns – Knee pain for hip problem – Arm and leg pains in spine lesions University of Pennsylvania
    [Show full text]
  • Osteoid Osteoma and Your Everyday Practice
    n Review Article Instructions 1. Review the stated learning objectives at the beginning cme ARTICLE of the CME article and determine if these objectives match your individual learning needs. 2. Read the article carefully. Do not neglect the tables and other illustrative materials, as they have been selected to enhance your knowledge and understanding. 3. The following quiz questions have been designed to provide a useful link between the CME article in the issue Osteoid Osteoma and your everyday practice. Read each question, choose the correct answer, and record your answer on the CME Registration Form at the end of the quiz. Petros J. Boscainos, MD, FRCSEd; Gerard R. Cousins, MBChB, BSc(MedSci), MRCS; 4. Type or print your full name and address and your date of birth in the space provided on the CME Registration Form. Rajiv Kulshreshtha, MBBS, MRCS; T. Barry Oliver, MBChB, MRCP, FRCR; 5. Indicate the total time spent on the activity (reading article and completing quiz). Forms and quizzes cannot be Panayiotis J. Papagelopoulos, MD, DSc processed if this section is incomplete. All participants are required by the accreditation agency to attest to the time spent completing the activity. educational objectives 6. Complete the Evaluation portion of the CME Regi stration Form. Forms and quizzes cannot be processed if the Evaluation As a result of reading this article, physicians should be able to: portion is incomplete. The Evaluation portion of the CME Registration Form will be separated from the quiz upon receipt at ORTHOPEDICS. Your evaluation of this activity will in no way affect educational1.
    [Show full text]
  • Craniofacial Chondrosarcomas: Imaging Findings in 15 Untreated Cases
    165 Craniofacial Chondrosarcomas: Imaging Findings in 15 Untreated Cases Ya-Yen Lee1 Radiographic findings of 15 untreated chondrosarcomas of the cranial and facial Pamela Van Tassel bones were reviewed. These tumors have a propensity to occur in the wall of a maxillary sinus, at the junction of sphenoid and ethmoid sinuses and vomer, and at the undersur­ face of the sphenoid bone. Because of its slow-growing nature, chondrosarcomas tend to be large, multi lobulated, and sharply demarcated when detected. Frequent bone changes are a combination of erosion and destruction, with sharp transitional zones and absent periosteal reaction. Tumor matrix calcifications, not necessarily chondroid, are almost always present. Both CT and MR may be necessary for thorough evaluation of tumor extent. Chondrosarcoma, a malignant but usually slow-growing cartilaginous tumor, constitutes approximately 11 % of malignant bone tumors [1] but rarely occurs in the craniofacial region . Because of its propensity to occur in the deep facial structures or base of the skull, the true extent and origin of the tumor may be overlooked if not properly evaluated radiographically. We review a relatively large series of craniofacial chondrosarcomas and discuss the differential diagnosis and choice of imaging technique. Materials and Methods This retrospective radiologic review was based on the pretreatment radiographic studies of 15 patients with craniofacial chondrosarcomas seen at our institution over a period of 40 years , excluding three intracranial dural chondrosarcomas, which are to be reported sepa­ rately. An attempt was also made to correlate the radiographic findings with the hi stologic grades of the tumors. The ages of the patients ranged from 10 to 73 years , with a mean of 40 years.
    [Show full text]
  • Bone and Soft Tissue Sarcomas
    Bone and Soft Tissue Sarcomas Changes to Pathology Codes in the 4th Edition of the World Health Organisation Classification of Bone and Soft Tissue Sarcomas September 2013 Page 1 of 17 Authors Mr Matthew Francis Cancer Analysis Development Manager, Public Health England Knowledge & Intelligence Team (West Midlands) Dr Nicola Dennis Sarcoma Analyst, Public Health England Knowledge & Intelligence Team (West Midlands) Ms Jackie Charman Cancer Data Development Analyst Public Health England Knowledge & Intelligence Team (West Midlands) Dr Gill Lawrence Breast and Sarcoma Cancer Analysis Specialist, Public Health England Knowledge & Intelligence Team (West Midlands) Professor Rob Grimer Consultant Orthopaedic Oncologist The Royal Orthopaedic Hospital NHS Foundation Trust For any enquiries regarding the information in this report please contact: Mr Matthew Francis Public Health England Knowledge & Intelligence Team (West Midlands) Public Health Building The University of Birmingham Birmingham B15 2TT Tel: 0121 414 7717 Fax: 0121 414 7712 E-mail: [email protected] Acknowledgements The Public Health England Knowledge & Intelligence Team (West Midlands) would like to thank the following people for their valuable contributions to this report: Dr Chas Mangham Consultant Orthopaedic Pathologist, Robert Jones and Agnes Hunt Orthopaedic and District Hospital NHS Trust Professor Nick Athanasou Professor of Musculoskeletal Pathology, University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences Copyright @ PHE Knowledge & Intelligence Team (West Midlands) 2013 1.0 EXECUTIVE SUMMARY Page 2 of 17 The 4th edition of the World Health Organisation (WHO) Classification of Tumours of Soft Tissue and Bone which was published in 2012 contains notable changes from the 2002 3rd edition. The key differences between the 3rd and 4th editions can be seen in Table 1.
    [Show full text]
  • What Is New in Orthopaedic Tumor Surgery?
    15.11.2018 What is new in orthopaedic tumor surgery? Marko Bergovec, Andreas Leithner Department of Orhtopaedics and Trauma Medical University of Graz, Austria 1 15.11.2018 Two stories • A story about the incidental finding • A scary story with a happy end The story about the incidental finding • 12-year old football player • Small trauma during sport • Still, let’s do X-RAY 2 15.11.2018 The story about the incidental finding • Panic !!! • A child has a tumor !!! • All what a patient and parents hear is: – bone tumor = death – amputation – will he ever do sport again? • Still – what now? 3 15.11.2018 A scary story with a happy end • 12-year old football player • Small trauma during sport • 3 weeks pain not related to physical activity • “It is nothing, just keep it cool, take a rest” 4 15.11.2018 A scary story with a happy end • A time goes by • After two weeks of rest, pain increases... • OK, let’s do X-RAY 5 15.11.2018 TUMORS benign vs malign bone vs soft tissue primary vs metastasis SARCOMA • Austria – cca 200 patients / year – 1% of all malignant tumors • (breast carcinoma = 5500 / year) 6 15.11.2018 Distribution of the bone tumoris according to patients’ age and sex 250 200 150 100 broj bolesnika broj 50 M Ž 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 80+ dob 7 15.11.2018 WHO Histologic Classification of Bone Tumors Bone-forming tumors Benign: Osteoma; Osteoid osteoma; Osteoblastoma Intermediate; Aggressive (malignant) osteoblastoma Malignant: Conventional central osteosarcoma; Telangiectatic osteosarcoma; Intraosseous well
    [Show full text]
  • Primary Tumors of the Spine
    280 Primary Tumors of the Spine Sebnem Orguc, MD1 Remide Arkun, MD1 1 Department of Radiology, Celal Bayar University, Manisa, Türkiye Address for correspondence Sebnem Orguc, MD, Department of 2 Department of Radiology, Ege University, İzmir, Türkiye Radiology, Celal Bayar University, Manisa, Türkiye (e-mail: [email protected]; [email protected]). Semin Musculoskelet Radiol 2014;18:280–299. Abstract Spinal tumors consist of a large spectrum of various histologic entities. Multiple spinal lesions frequently represent known metastatic disease or lymphoproliferative disease. In solitary lesions primary neoplasms of the spine should be considered. Primary spinal tumors may arise from the spinal cord, the surrounding leptomeninges, or the extradural soft tissues and bony structures. A wide variety of benign neoplasms can involve the spine including enostosis, osteoid osteoma, osteoblastoma, aneurysmal bone cyst, giant cell tumor, and osteochondroma. Common malignant primary neo- plasms are chordoma, chondrosarcoma, Ewing sarcoma or primitive neuroectodermal Keywords tumor, and osteosarcoma. Although plain radiographs may be useful to characterize ► spinal tumor some spinal lesions, magnetic resonance imaging is indispensable to determine the ► extradural tumor extension and the relationship with the spinal canal and nerve roots, and thus determine ► magnetic resonance the plan of management. In this article we review the characteristic imaging features of imaging extradural spinal lesions. Spinal tumors consist of a large spectrum of various histo- Benign Tumors of the Osseous Spine logic entities. Primary spinal tumors may arise from the spinal cord (intraaxial or intramedullary space), the sur- Enostosis rounding leptomeninges (intradural extramedullary space), Enostosis, also called a bone island, is a frequent benign or the extradural soft tissues and bony structures (extra- hamartomatous osseous spinal lesion with a developmental dural space).
    [Show full text]
  • Peripheral Osteoma of the Mandible a Report of Two Cases and Review of Literature
    Journal of Research in Medical and Dental Science 2020, Volume 8, Issue 6, Page No: 176-179 Copyright CC BY-NC 4.0 Available Online at: www.jrmds.in eISSN No. 2347-2367: pISSN No. 2347-2545 Peripheral Osteoma of the Mandible a Report of Two Cases and Review of Literature Jawahar Anand*, Anil Kumar Desai, Sayali Desai Department of Oral and Maxillofacial Surgery, Craniofacial Unit and Research Centre, SDM College of Dental Sciences, Dharwad, Karnataka, India ABSTRACT Osteoma is a benign osteogenic tumour, commonly involving the craniofacial bones. It is characterized by excessive proliferation of cortical or cancellous bone. It can be of the central, peripheral or extraskeletal variety. Peripheral osteoma arises from the periosteum and is usually asymptomatic, however, can attain large size in the involved bone. In this paper, we report two cases of peripheral osteoma and review the literature related to the pathological condition. Two patients reported with a chief complaint of asymptomatic slow-growing swelling over the mandibular body region. Radiographic examination revealed a lobulated pedunculated radiopaque mass. It was excised surgically, and no recurrence was noted on follow-up visits. Osteoma involving the jaws is not common and can be associated with Gardner’s syndrome thereby requiring regular follow-up and thorough examination. Surgical excision is the treatment of choice and recurrence is rare. Key words: Peripheral osteoma, Mandibular osteoma, Benign tumour, Osteogenic tumour. HOW TO CITE THIS ARTICLE Review of Literature, J Res Med Dent Sci, 2020, 8 (6): 176-179. : Jawahar Anand, Anil Kumar Desai, Sayali Desai, Peripheral Osteoma of the Mandible a Report of Two Cases and Corresponding author: Jawahar Anand purpose of this paper is to report two cases of e-mail: [email protected] osteomas involving the mandibular body and Received: 27/08/2020 present a review of the literature.
    [Show full text]
  • Osteoid Osteoma of Mandibular Bone Case Report and Review of The
    Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 31 (2019) 322–326 Contents lists available at ScienceDirect Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology journal homepage: www.elsevier.com/locate/jomsmp Osteoid osteoma of mandibular bone: Case report and review of the T literature ⁎ Takashi Maeharaa, ,1, Yuka Murakamia,1, Shintaro Kawanoa, Yurie Mikamia, Tamotsu Kiyoshimab, Toru Chikuic, Noriko Kakizoea, Ryusuke Munemuraa, Seiji Nakamuraa a Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan b Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan c Department of Oral and Maxillofacial Radiology, Faculty of Dental Science, Ktyushu University, Fukuoka, Japan ARTICLE INFO ABSTRACT Keywords: Osteoid osteoma is a benign bone-forming tumor and characterized by its limited growth potential, not Osteoid osteoma exceeding 2 cm. The radiological hallmark of this tumor is a nidus, which is a small round area of relative Osteoblastoma radiolucency. Osteoid osteoma can involve any bone but is most commonly found in long bones and is Osteosarcoma extremely rare in the head and neck region. This disease characteristically presents with dull pain, worse Nidus at night, and sometimes relieved with NSAIDs. A 24-year-old Japanese woman presented with spontaneous Mandible pain and tenderness on the lingual side of her mandibular second molar on the right side. The patient reported that her pain had gradually increased, becoming more continuous and severe and no longer responding to NSAIDs. An initial panoramic radiograph revealed an oval, internally non-uniform, some- what obscure boundaries in the right mandible.
    [Show full text]
  • Differential Diagnosis of Calvarial Tumors: a Series of 8 Cases
    Published online: 2021-05-25 THIEME Original Article 1 Differential Diagnosis of Calvarial Tumors: A Series of 8 Cases Jitesh Kumar Sharma1 Rashim Kataria1 Madhur Choudhary1 Devendra Kumar Purohit1 1Department of Neurosurgery, SMS Medical College, Jaipur, Address for correspondence Devendra Kumar Purohit, MS, Mch, Rajasthan, India Department of Neurosurgery, SMS Medical College, Jaipur 302004, Rajasthan, India (e-mail: [email protected]). Indian J Neurosurg Abstract Introduction To present and discuss the clinical presentations, investigations, and treatment options for skull bone tumors. Materials and Methods This study was conducted from January 2019 to December 2019 at the Department of Neurosurgery. During this period, eight patients presented with skull bone tumor in the outpatient department. All patients were thoroughly investigated. Surgery was conducted on six patients and two patients had dissemi- nated carcinoma; hence, surgery was not done. Patients were regularly followed-up after the surgery. Results In our study, out of eight cases, five were females and three were males. We had two cases of fibrous dysplasia, two cases of osteomas, and one case each of brown tumor, metastases from lung carcinoma, metastases from follicular carcinoma of thy- roid, and Ewing sarcoma/primitive neuroectodermal tumor (PNET). Excision of tumor Keywords was performed where indicated and adjuvant chemo- and radiotherapy was suggested ► skull tumors wherever required. ► benign skull tumor Conclusion Bony tumors of the skull are uncommon diseases for the neurosurgeons. ► malignant skull These tumors require a careful diagnosis with suitable radiological examinations and tumors proper clinical correlation for proper management. Introduction benign skull tumors can be cartilage-forming, bone-forming, tumor of blood or blood vessels, tumor of connective tis- Skull tumors are uncommon lesions, making up < 2% of all sues, Paget disease, or epidermoid, dermoid, or aneurysmal 1 the musculoskeletal tumors.
    [Show full text]
  • Evaluation of Some Histochemical and Immunohistochemical Criteria of Round Cell Tumors of Bone Eman M
    Original article 21 Evaluation of some histochemical and immunohistochemical criteria of round cell tumors of bone Eman M. S. Muhammada, Zeinab H. El-badawia, Sana S. Krooshc and Hassan H. Noamanb Departments of aPathology, bOrthopedic Surgery, Background/aims Faculty of Medicine, University of Sohag, Sohag and cDepartment of Pathology, Faculty of Medicine, The differential diagnosis of round cell tumors of bone (RCTB), Ewing sarcoma, small- University of Assiut, 82524 Assiut, Egypt cell osteosarcoma, mesenchymal chondrosarcoma, osteoblastoma, chondroblastoma, Correspondence to Eman M. S. Muhammad, primary bone lymphoma, and multiple myeloma still remains a challenge. Given the Department of Pathology, Faculty of Medicine, significant differences in treatment, an accurate diagnosis is crucial. This study aimed University of Sohag, Sohag, Egypt Tel:+ 02 093 460 2963; e-mail: [email protected] to evaluate some histochemical and immunohistochemical criteria of RCTB. Participants and methods Received 29 January 2012 Accepted 6 March 2012 Periodic acid-Schiff (PAS), CD99, CD138, osteocalcin, and leukocyte common antigen (LCA) were evaluated in 113 patients with RCTB. Journal of the Arab Society for Medical Research 2012, 7:21–32 Results PAS was positive in neoplastic cells of all Ewing sarcomas, 27% of osteosarcomas, 92% of chondrosarcomas, all osteoblastomas and chondroblastomas, and the osteoid tissue of all osteosarcomas and osteoblastomas. CD99 was positive in all Ewing sarcomas, in 11, 4, and 11% of osteoblastomas, multiple myelomas, and bone lymphomas, respectively. CD99 was higher in Ewing sarcoma than in other RCTB (Po0.0001). Osteocalcin was positive in neoplastic cells of all osteosarcomas, osteoblastomas, and 20% of chondroblastomas, 84, and 78% of osteoid of osteosarcomas and osteoblastomas, respectively.
    [Show full text]